In a recorded phone call between a vaccine victim and a representative of Moderna, the rep admitted that everyone that subjects themselves to the vaccine is a participant in the trial.

He also admits long-term protective efficacy against Covid-19.

The woman on the phone call is suffering from Guillain-Barré syndrome after her first dose and recorded the conversation with this Moderna representaive.